Bruder Consulting & Venture Group’s Post

#DidYouKnow that chemical characterization and toxicological risk assessment can be used to address selected biocompatibility endpoints for medical devices, but it is challenging to get aligned with FDA on all the details. FDA’s new Draft Guidance on Chemical Analysis provides insight into the Agency’s thinking, but there’s still considerable variation from team to team within FDA. We can get formal FDA feedback on your chemical characterization plans to give you certainty that your completed testing will meet FDA’s expectations!   How can we support your business goals? DM us or visit our website to connect! #ClientPartners #biotech #managementconsulting #FDA #IntegratedInsights

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics